These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11250808)

  • 1. Methods to identify and characterize developmental neurotoxicity for human health risk assessment. I: behavioral effects.
    Cory-Slechta DA; Crofton KM; Foran JA; Ross JF; Sheets LP; Weiss B; Mileson B
    Environ Health Perspect; 2001 Mar; 109 Suppl 1(Suppl 1):79-91. PubMed ID: 11250808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional assays for neurotoxicity testing.
    Moser VC
    Toxicol Pathol; 2011 Jan; 39(1):36-45. PubMed ID: 21075917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment strategies for neuroprotective agents.
    Slikker W; Gaylor DW
    Ann N Y Acad Sci; 1995 Sep; 765():198-208; discussion 209. PubMed ID: 7486606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurobehavioral aspects of developmental toxicity testing.
    Ulbrich B; Palmer AK
    Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):407-12. PubMed ID: 9182049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral toxicology in the 21st century: challenges and opportunities for behavioral scientists. Summary of a symposium presented at the annual meeting of the neurobehavioral teratology society, June, 2009.
    Bushnell PJ; Kavlock RJ; Crofton KM; Weiss B; Rice DC
    Neurotoxicol Teratol; 2010; 32(3):313-28. PubMed ID: 20171276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobehavioral methods used in neurotoxicological research.
    Tilson HA
    Toxicol Lett; 1993 May; 68(1-2):231-40. PubMed ID: 8516768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of developmental neurotoxicology studies in risk assessment.
    Tilson HA
    Toxicol Pathol; 2000; 28(1):149-56. PubMed ID: 10669002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmasking silent neurotoxicity following developmental exposure to environmental toxicants.
    Kraft AD; Aschner M; Cory-Slechta DA; Bilbo SD; Caudle WM; Makris SL
    Neurotoxicol Teratol; 2016; 55():38-44. PubMed ID: 27049787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations.
    Dorman DC; Allen SL; Byczkowski JZ; Claudio L; Fisher JE; Fisher JW; Harry GJ; Li AA; Makris SL; Padilla S; Sultatos LG; Mileson BE
    Environ Health Perspect; 2001 Mar; 109 Suppl 1(Suppl 1):101-11. PubMed ID: 11250810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of attention and inhibitory control in rodent developmental neurotoxicity studies.
    Driscoll LL; Strupp BJ
    Neurotoxicol Teratol; 2015; 52(Pt A):78-87. PubMed ID: 25224214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods to identify and characterize developmental neurotoxicity for human health risk assessment: overview.
    Mileson BE; Ferenc SA
    Environ Health Perspect; 2001 Mar; 109 Suppl 1(Suppl 1):77-8. PubMed ID: 11250807
    [No Abstract]   [Full Text] [Related]  

  • 12. Building a scientific framework for studying hormonal effects on behavior and on the development of the sexually dimorphic nervous system.
    Li AA; Baum MJ; McIntosh LJ; Day M; Liu F; Gray LE
    Neurotoxicology; 2008 May; 29(3):504-19. PubMed ID: 18502513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicology risk assessment guidelines: developmental neurotoxicology.
    Tilson HA
    Neurotoxicology; 2000; 21(1-2):189-94. PubMed ID: 10794399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral toxicology, risk assessment, and chlorinated hydrocarbons.
    Evangelista de Duffard AM; Duffard R
    Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):353-60. PubMed ID: 9182042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The developmental neurotoxicity of arsenic: cognitive and behavioral consequences of early life exposure.
    Tolins M; Ruchirawat M; Landrigan P
    Ann Glob Health; 2014; 80(4):303-14. PubMed ID: 25459332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal behavioral methods in neurotoxicity assessment: SGOMSEC joint report.
    Kulig B; Alleva E; Bignami G; Cohn J; Cory-Slechta D; Landa V; O'Donoghue J; Peakall D
    Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):193-204. PubMed ID: 8860322
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of aldicarb and methamidophos neurotoxicity at different ages in the rat: behavioral and biochemical parameters.
    Moser VC
    Toxicol Appl Pharmacol; 1999 Jun; 157(2):94-106. PubMed ID: 10366542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model studies for evaluating the neurobehavioral effects of complex hydrocarbon solvents II. Neurobehavioral effects of white spirit in rat and human.
    Lammers JH; Emmen HH; Muijser H; Hoogendijk EM; McKee RH; Owen DE; Kulig BM
    Neurotoxicology; 2007 Jul; 28(4):736-50. PubMed ID: 17433444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zebrafish as potential model for developmental neurotoxicity testing: a mini review.
    de Esch C; Slieker R; Wolterbeek A; Woutersen R; de Groot D
    Neurotoxicol Teratol; 2012; 34(6):545-53. PubMed ID: 22971930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing for cognitive function in animals in a regulatory context.
    Bushnell PJ
    Neurotoxicol Teratol; 2015; 52(Pt A):68-77. PubMed ID: 24815542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.